Inovio Pharmaceuticals
INO
INO
118 hedge funds and large institutions have $95.2M invested in Inovio Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less call options, than puts
Call options by funds: $71K | Put options by funds: $124K
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
118
Holding in Top 10
–
Calls
$71K
Puts
$124K
Top Buyers
| 1 | +$558K | |
| 2 | +$558K | |
| 3 | +$549K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$516K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$237K |
Top Sellers
| 1 | -$429K | |
| 2 | -$297K | |
| 3 | -$214K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$213K |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$191K |